MCC-135
01-02-TL-MCC135-001
Phase 2 small_molecule completed
Quick answer
MCC-135 for Congestive Heart Failure is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Congestive Heart Failure
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed